Cas 862686-38-2,(S)-1-(4-amino-phenyl)-pyrrolidine-2-carboxylic acid dimethylamide

862686-38-2

Post Buying Request

Basic information

Product Name: (S)-1-(4-amino-phenyl)-pyrrolidine-2-carboxylic acid dimethylamide
Synonyms: (S)-1-(4-amino-phenyl)-pyrrolidine-2-carboxylic acid dimethylamide
CAS NO:862686-38-2
Molecular Formula:
Molecular Weight: 233.313
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (S)-1-(4-amino-phenyl)-pyrrolidine-2-carboxylic acid dimethylamide(CAS DataBase Reference)
NIST Chemistry Reference: (S)-1-(4-amino-phenyl)-pyrrolidine-2-carboxylic acid dimethylamide(862686-38-2)
EPA Substance Registry System: (S)-1-(4-amino-phenyl)-pyrrolidine-2-carboxylic acid dimethylamide(862686-38-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 862686-38-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

862686-38-2 Suppliers

Recommended suppliers

862686-38-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 862686-38-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,2,6,8 and 6 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 862686-38:
(8*8)+(7*6)+(6*2)+(5*6)+(4*8)+(3*6)+(2*3)+(1*8)=212
212 % 10 = 2
So 862686-38-2 is a valid CAS Registry Number.

862686-38-2Upstream product

566159-08-8 (2R)-N,N-dimethylpyrrolidine-2-carboxamide

862686-38-2Downstream Products

862686-38-2Relevant academic research and scientific papers

IMIDAZOLO-5-YL-2-ANILINOPYRIMIDINES AS AGENTS FOR THE INHIBITION OF CELL PROLIFERATION

-

Page/Page column 110, (2010/02/13)

Compounds of the formula (I), wherein variable groups are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti cell proliferation) effect in a warm blooded animal, such as man.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 862686-38-2